Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC)

P. Kopinski (Bydgoszcz, Poland)

Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Session: Lung cancer - basic science: the latest results from the bench
Session type: Thematic Poster
Number: 4212
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kopinski (Bydgoszcz, Poland). Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC). 4212

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

What surgery for which bronchiolo-alveolar carcinoma?
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

Apoptosis of circulating and BALF lymphocytes of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004

Bronchoalveolar lavage in patients with acute lung toxicity after chemo-radiotherapy for lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Cellular changes in BAL fluid may reflect immunity in patients with lung cancer
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005

A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011